Nirvana Life Sciences Inc NIRVF

Morningstar Rating
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover NIRVF, but with our powerful screener, you can find stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
26,000 / 26,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees

Valuation

Metric
NIRVF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NIRVF
Quick Ratio
0.02
Current Ratio
0.05
Interest Coverage
−177.88
Quick Ratio
NIRVF

Profitability

Metric
NIRVF
Return on Assets (Normalized)
−609.51%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
NIRVF

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk AS ADR
NVO
TscdrzvjxGrd$512.4 Bil
Vertex Pharmaceuticals Inc
VRTX
TxrgpbjMnwhww$117.5 Bil
Regeneron Pharmaceuticals Inc
REGN
LcggpsmVngyqp$111.6 Bil
Alnylam Pharmaceuticals Inc
ALNY
ZpcyqlrtmHtfqr$34.4 Bil
argenx SE ADR
ARGX
NwrypfbNyy$31.7 Bil
BioNTech SE ADR
BNTX
MkscjqgxCzxkm$29.2 Bil
Moderna Inc
MRNA
WnvkbpfcGgnv$23.1 Bil
United Therapeutics Corp
UTHR
QhlfdbdHnnrb$15.8 Bil
Biomarin Pharmaceutical Inc
BMRN
HbsccztYjbzmq$13.2 Bil
Incyte Corp
INCY
LkmjdtbNvhbnx$13.0 Bil

Sponsor Center